The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders.

Reimers, Arne; Ljung, Hanna

Reimers, Arne; Ljung, Hanna.

Affiliation

Reimers A; Department of Clinical Chemistry and Pharmacology, Division of Laboratory Medicine, Klinikgatan 17, Lund, 22185, Sweden.
Ljung H; Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden.

Ther Adv Psychopharmacol ; 9: 2045125319858901, 2019.

Article de En | MEDLINE | ID: mdl-31258889

Mots clés

DHA; EPA; clinical studies; n-3 PUFAs; n-3 index; n-6/n-3 ratio; neurologic disorders; neuropsychiatric disorders; psychiatric disorders

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Ther Adv Psychopharmacol Année: 2019 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google